 Home > Medical News >

Medical Research Articles

Merck Mavenclad (Krakowbin tablets) approved by the Swiss Medical Products Authority for the treatment of recurrent remission multiple sclerosis

 Time of Update: 2020-06-10

10 8 performance beat key finder inchi key endometriosis clinical trials active ingredient mouthwash

recently, Merck KGaA announced that Mavenclad (cladrine tablets) has been approved by the Swiss Medical (http:// product (http:// Authority for the treatment of highly active recurrent recurren
European Commission approves Tiwa Ajovy preventive treatment for migraines

 Time of Update: 2020-06-10

proteinase 3 antibody option ajovy injection sinkholes united states lice treatment target

recently, Israel's Pharmaceutical (http:// giant Teva announced that the European Commission (EC) has approved Ajovy (fremanezumab) 225mg injection pre-charged syringe for adult patients with mig
Johnson Stelara (ustekinumab) reaches major endpoint in Phase 3 clinical trial for severe ulcerative colitis in treatment

 Time of Update: 2020-06-10

uc 2 imuran crohn's disease minerals human body immune globulin therapy phase contrast microscope

today, Janssen, a subsidiary of Johnson and Johnson's company, (http:// , announced that its development of Steeinumab had reached its main end in a phase 3 clinical trial (http:// of severe ul
FDA approves Xellia Pharmaceuticalready pre-mixed vancomycin injection

 Time of Update: 2020-06-10

what cromolyn sodium 400 mg infectious disease news sodium nitrite sds wellbutrin 300 mg

recently, Xellia Pharmaceutical (http:// company (http:// announced that the U.S Food and Medicines (http:// Administration ( FDA (http:// ) has approved the ready-to-use (RTU) premixed van
Aishi announced that its original anti-epileptic drug, the anti-epileptic drug Varempanai (Weiketai ®), was accepted for the new drug market in China

 Time of Update: 2020-06-10

phenytoin generic name ambient drug lego drug lamivudine brand name journal name

Recently, , Aishi Announced that its original anti-epileptic drug (http:// (AED) http:// (AED) name: Fycompa ®; Chinese Product Name: ®) in China, New Drug (http:// to be accepted in October
FDA Grants AstraZeneca MEDI8897 Breakthrough Treatment Designation

 Time of Update: 2020-06-10

dnage medical medical premium phase locked loops evaluating margin safety track

, pharmaceutical (http:// giant AstraZeneca announced that the u.S Food and Drug (http:// Administration ( FDA (http:// ) has granted MEDI8897 breakthrough treatment designation (BTD) In Marc
Bollinger Ingeheim's new drug Arti-Cell® Forte to be listed in Europe

 Time of Update: 2020-06-10

approved average global temperature orchid stem coli long symptoms cognitive health solutions

lameness is a common problem for horses and has an impact on their performance and animal welfare Current treatments cannot address the needs of all cases, and the industry is looking forward to inn
Arnaud Pharmaceutical Lysooma Virus Product Pelareorep (AN1004) approved by NMPA for clinical trial

 Time of Update: 2020-06-10

manic phase lurie cancer center formaldehyde phase 2 quantum phase transition non invasive cancer

today, the of the Medicines (http:// announced that its ossotic virus product Pelareorep (AN1004) has been approved by the National Food Medicines (http:// Regulatory Authority (NMPA) clinical
FDA Grants MB-102 (CD123 CAR-T) Orphan Drug For BPDCN

 Time of Update: 2020-06-10

pseudoephedrine drug test recombinant human albumin aleve drug interactions colchicine drug ghb drug test

recently, Mustang Bio (http:// announced that the u.S Food and Drug (http:// Administration ( FDA (http:// ) has granted MB-102 (CD123 CAR-T) the status of orphan drug for the treatment of pa
FDA approves Tosymra for acute treatment for headache attacks in migraine patients

 Time of Update: 2020-06-10

nasal spray epinephrine pain zapper relief clonazepam drug test rubella test results lasix 10 mg

recently, Dr Reddy's (http:// and its subsidiary Promius Pharma announced that the U.S FDA (http:// approved the launch of Tosymra as an acute treatment for migraine attacks in migraine patien
Xi'an Yangsen's Zei yu ® (Acetate Abitron tablets) new indications approved by the State Drug Administration

 Time of Update: 2020-06-10

all red 4 amyl nitrate drug 3 8 7 8 all ds what co 2

prostate cancer is the most common urogenital cancer in Chinese men, with a national incidence rate of 9.8 per 100,000 people and a high rate of 12.07 percent per year yesterday (December 4), Johns
Roche submits a license to the FDA to supplement biologics to the anti-cancer drug Kadcyla

 Time of Update: 2020-06-10

aav gene therapy cancer detection neratinib breast cancer stem cell therapy stroke positive displacement pipette

recently, Roche, the swiss pharmaceutical (http:// giant, announced that it had submitted to the u.S Food and Drug (http:// Administration ( FDA (http:// a supplementary biological product
A copy of the anti-epileptic drug Fycompa (perampanel, Verlampane) was submitted to THE EMA

 Time of Update: 2020-06-10

endometriosis clinical trial clinical supplies long spf 50 pegs social studies ampa receptor

recently, Eisai, a Japanese drugmaker, announced that it had submitted an application to the European Medicines (http:// Authority (EMA) for the anti-epileptic drug Fycompa (perampana) to approve
10% of vimpat (lacosamide, lacamide) ® dry syrup is available in Japan

 Time of Update: 2020-06-10

selling drugs 2018 new antidepressant drug boiler water treatment morphine drug class ultrapure water system

recently, Belgium's Pharmaceutical (http:// giant UCB Japan sub- company (http:// UCB Japan Co and First Third Pharmaceuticals announced that 10 percent of the ® dry syrup of The Lacosamide (l
Xi'an Yangsen-type ® (injection with Invrisi monoantigen) approved by the State Drug Administration

 Time of Update: 2020-06-10

lexapro class dipyridamole drug class 2 5 hexanedione colace drug class 3 8 1 4

Today, Xi'an Yangsen Pharmaceutical (http:// Limited Company (http:// announced that the National Drug (http:// Supervisory Authority has approved the ® (REMICADE®), i.e injected with infri
Changchun Haiyue Hedara fofi first imitation approved by the State Bureau for listing

 Time of Update: 2020-06-10

10 22 cleaning urban review long acting antipsychotics il 5 inhibitor melatonin trade name

On February 17, , the State Administration announced the approval of the Drug (http:// , and Changchun Haiyue Tadalajara was approved for the first time Changchun Hyatt Pharmaceuticals declared pro
Fda approves AYCAZ ® for supplementary listing of cUTI and cIAI for treatment of children over 3 months of time

 Time of Update: 2020-06-10

8 9 simplified lead 1 2 3 heroin drug class investigational new drug 1 2 dichloroethene

recently, Allergan (http:// announced that the U.S FDA http:// has approved its drug (http:// AVYCAZ ® (ceftazidime-cephalosporine and avibactam) for complex intra-abdominal infections (cUT
FDA approves Precigen's PRGN-3006 Research New Drug (IND) Application

 Time of Update: 2020-06-10

what cell therapy increase androgen receptors ind clinical trial role cell membrane cell express

Precigen, a of intrexon's wholly owned company, (http:// signed a new licensing agreement with Ziopharm in October , however, Precigen announced that FDA (http:// has approved its prGN-3006 re
Intercept reaches major end in phase 3 trial of new drug Ocacic acid (OCA)

 Time of Update: 2020-06-10

liver cirrhosis images hepatitis symptoms women bumex 1 mg 10 3 soow quartz level 1

NASH is a progressive liver disease caused by excessive accumulation of fat in the liver, which can lead to chronic inflammation of the liver, trigger progressive liver fibrosis, cirrhosis, and ultim
CHMP expresses support for bluebird bio's application for listing of Genenology Zynteglo

 Time of Update: 2020-06-10

carboxyhemoglobin test acid phosphatase test saliva test test osteoarthritis vegf test

recently, bluebird bio announced that the European Medicines (http:// Authority (EMA) has expressed its support for its application for approval (MAA) for gene therapy Zynteglo (formerly Known le

Go to Page

Medical Research Articles

Merck Mavenclad (Krakowbin tablets) approved by the Swiss Medical Products Authority for the treatment of recurrent remission multiple sclerosis

European Commission approves Tiwa Ajovy preventive treatment for migraines

Johnson Stelara (ustekinumab) reaches major endpoint in Phase 3 clinical trial for severe ulcerative colitis in treatment

FDA approves Xellia Pharmaceuticalready pre-mixed vancomycin injection

Aishi announced that its original anti-epileptic drug, the anti-epileptic drug Varempanai (Weiketai ®), was accepted for the new drug market in China

FDA Grants AstraZeneca MEDI8897 Breakthrough Treatment Designation

Bollinger Ingeheim's new drug Arti-Cell® Forte to be listed in Europe

Arnaud Pharmaceutical Lysooma Virus Product Pelareorep (AN1004) approved by NMPA for clinical trial

FDA Grants MB-102 (CD123 CAR-T) Orphan Drug For BPDCN

FDA approves Tosymra for acute treatment for headache attacks in migraine patients

Xi'an Yangsen's Zei yu ® (Acetate Abitron tablets) new indications approved by the State Drug Administration

Roche submits a license to the FDA to supplement biologics to the anti-cancer drug Kadcyla

A copy of the anti-epileptic drug Fycompa (perampanel, Verlampane) was submitted to THE EMA

10% of vimpat (lacosamide, lacamide) ® dry syrup is available in Japan

Xi'an Yangsen-type ® (injection with Invrisi monoantigen) approved by the State Drug Administration

Changchun Haiyue Hedara fofi first imitation approved by the State Bureau for listing

Fda approves AYCAZ ® for supplementary listing of cUTI and cIAI for treatment of children over 3 months of time

FDA approves Precigen's PRGN-3006 Research New Drug (IND) Application

Intercept reaches major end in phase 3 trial of new drug Ocacic acid (OCA)

CHMP expresses support for bluebird bio's application for listing of Genenology Zynteglo